STEVEN EVANS: Open Payments
NPI 1568122000 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,030 in 81 payments from 17 companies in 2025. Trend: 2023 $1,482 · 2024 $1,981 · 2025 $2,030
Food & beverage: $1,946Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $537 |
| Janssen Biotech, Inc. | 28 | $489 |
| PFIZER INC. | 12 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| Ardelyx, Inc. | 1 | $128 |
| Celltrion USA Inc. | 4 | $85 |
| Phathom Pharmaceuticals, Inc. | 2 | $62 |
| GENZYME CORPORATION | 2 | $55 |
| Novo Nordisk Inc | 2 | $41 |
Products named: TREMFYA, SKYRIZI, RINVOQ, XIFAXAN, IBSRELA, VELSIPITY, VEGZELMA, DUPIXENT.
Industry payments across NV — which companies pay providers there.
